Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Central nervous system stimulants disorder

Substance-Induced Anxiety Disorder. Numerous medicines and drugs of abuse can produce panic attacks. Panic attacks can be triggered by central nervous system stimulants such as cocaine, methamphetamine, caffeine, over-the-counter herbal stimulants such as ephedra, or any of the medications commonly used to treat narcolepsy and ADHD, including psychostimulants and modafinil. Thyroid supplementation with thyroxine (Synthroid) or triiodothyronine (Cytomel) can rarely produce panic attacks. Abrupt withdrawal from central nervous system depressants such as alcohol, barbiturates, and benzodiazepines can cause panic attacks as well. This can be especially problematic with short-acting benzodiazepines such as alprazolam (Xanax), which is an effective treatment for panic disorder but which has been associated with between dose withdrawal symptoms. [Pg.140]

Narcotics (Figure 90) are stimulants which are active on the central nervous system causing disorders and some temporary or permanent changes in this system and behaviour. Serious negative consequences of narcotics include dependence, a chronic disorder. [Pg.169]

Adderall XR (package insert). Wayne, PA, Shire US Inc, 2004 Angrist B, d Hollosy M, Sanfilipo M, et al Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment. J Clin Psychophamiacol 12 268—272, 1992 Arnold LE, Lindsay RL, Connors CK, et al A douhle-hlind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention-deficit hyperactivity disorder. I Am Acad Child Adolesc Psychiatry 14 542—554, 2004 Belle DJ, Ernest CS, Sauer JM, et al Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics. I Clin Pharmacol 42 1219-1227, 2002... [Pg.193]

One of the oldest uses for dextroamphetamines is in the treatment of narcolepsy, a sleep disorder characterized by constant daytime fatigue and sleepiness, with a disturbance in nighttime REM sleep (the period of sleep when dreams occur). During the day or other periods of time when they would normaly be awake, people with narcolepsy often experience sudden episodes of REM sleep. They may also suffer from sleep paralysis and/or cataplexy, an abmpt, total loss of muscle control. Central nervous system stimulants like dextroamphetamine help to relieve these symptoms. [Pg.139]

Amphetamines and similar central nervous system stimulants have been available for many years, but the substantial abuse liability and potential cardiovascular adverse effects have largely limited their use to the treatment of narcolepsy and attention-deficit-hyperactivity disorder. There has also been some utilization of amphetamines to combat sleepiness during military operations. [Pg.548]

Central Nervous System Disorders. Clinicians should be cautious when using topically applied central nervous system stimulants such as cyclopentolate. High concentrations of these drugs in normal children, and occasionally in adults, have resulted in transient central nervous system effects. The use of topical P-blockers for treatment of glaucoma has been associated with central nervous system side effects, including depression, fatigue, weakness, confusion, memory loss, headaches, and anxiety. [Pg.6]

Central Nervous System Stimulants Central nervous system stimulants include agents such as the amphetamines (Dexedrine) and methylphenidate hydrochloride (Ritalin), used to elevate mood, suppress appetite, and control hyperkinetic disorders in children. Other examples include the illegal drugs methamphet-amine and cocaine. The mechanism of action of these drugs is to augment actions of the adrenergic nervous system. [Pg.718]

Methylphenidate (MPH, Ritalin ) is a central nervous system stimulant that is used for the treatment of attention deficit disorders, with and without hyperactivity, and narcolepsy. MPH has two chiral centres and is marketed as a racemic mixture. It is known that d-threo-MP is pharmacologically more active than l-threo-MPH. The drag is rapidly metabohzed in humans to the inactive ritalinic acid. High-throughput analysis with chiral selectivity is demanded for the bioanalysis of MPH and its major metabolite. [Pg.302]

Several medical, medication-induced, or substance-related causes of mania and depression have been identified (see Table 68-2 for causes of mania and Table 67-1 in Chap. 67 on depressive disorders for causes of depression). " A complete medical, psychiatric, and medication history physical examination and laboratory testing are necessary to rule out any organic causes of mania or depression. An accurate diagnosis is important because some psychiatric and neurologic disorders present with manic-like symptoms. For example, attention-deficit/hyperactivity disorder and a manic episode have similar characteristics thus individuals with bipolar disorder may be misdiagnosed and prescribed central nervous system stimulants. Use of any substance that affects the central nervous system (e.g., alcohol, antidepressants, caffeine, central nervous system stimulants, hallucinogens, or marijuana) can worsen symptoms and decrease the... [Pg.1259]

Amphetamine, methamphetamine and ephedrine all have similar structures and each has two enantiomers. Amphetamine is a central nervous system stimulant and an anorexic. Methamphetamine is also an anorexic and is frequently used for treating attention disorders with hyperactivity. Ephedrine, on the other hand, although of similar structure has quite different physiological effects. Ephedrine (1) is a commonly used as a bronchodilator whereas (d) ephedrine (pseudoephedrine) is used as a decongestant. The separation of the six isomers of amphetamine, methamphetamine and ephedrine is shown in figure 6.17. [Pg.168]

Tolylaldehyde glyceryl acetyl N/A Central nervous system stimulants, treat attention deficit hyperactivity disorder (Drugbank)... [Pg.120]

The securinega alkaloids occur in several species of the Securinega and Phyllan-thus genera (150). Securinine was first isolated from the leaves and stems of Securinega suffruticosa (Euphorbiaceae). Securinine nitrate is a central nervous system stimulant similar to strychnine but less toxic. It was found to be useful in treatment of paresis and paralysis following infectious diseases and psychic disorders. The related alkaloids were obtained from Securinega suffruticosa allose-curinine, dihydrosecurinine, securinol A, and securinol B from the leaves, and securitinine from the roots. [Pg.208]

In this rapidly evolving field, the detection of PDE enzymes in the central nervous system (CNS) has stimulated interest in exploring potential applications of PDE inhibitors for treating CNS disorders such as Alzheimer s disease and other cognitive malfunctions, depression, anxiety, and schizophrenia. This review will focus on these therapeutic opportunities as well as new developments in the medicinal chemistry and biology associated with selected members of the PDE family, in particular PDEs 2, 4, 9, and 10. There have been a number of other reviews in this field in the past year that have covered selected individual PDE enzymes and potential pharmacologic applications of PDE inhibitors in CNS disorders [3,7,8]. [Pg.4]

In experimental typhoid disease in mice treated with colimycin, the addition of pentoxyl prevents immunological disorders and stimulates an immunological reaction [294]. This compound potentiates the action of sulphonamides in mice infected with type II pneumococcus [295]. In combination with streptomycin, pentoxyl is beneficial in the treatment of experimental tuberculosis in guinea-pigs [296]. However, a single pharmacological report, relative to effects on the central nervous system, was unfavourable [297]. [Pg.298]

Atomoxetine is a selective inhibitor of the norepinephrine reuptake transporter. Its actions, therefore, are mediated by potentiation of norepinephrine levels in noradrenergic synapses. It is used in the treatment of attention deficit disorders (see below). Atomoxetine has surprisingly little cardiovascular effect because it has a clonidine-like effect in the central nervous system to decrease sympathetic outflow while at the same time potentiating the effects of norepinephrine in the periphery. However, it may increase blood pressure in some patients. Norepinephrine reuptake is particularly important in the heart, particularly during sympathetic stimulation, and this... [Pg.188]

Ephedra, Ma-huang Diet aid stimulant bronchodilator Central nervous system toxicity, cardiac toxicity Avoid in patients at risk for stroke, myocardial infarction, uncontrolled blood pressure, seizures, general anxiety disorder... [Pg.1354]

Prescription medications such as pain relievers, central nervous system (CNS) depressants (tranquilizers and sedatives), and stimulants are highly beneficial treatments for a variety of health conditions. Pain relievers enable individuals with chronic pain to lead productive lives tranquilizers can reduce anxiety and help patients with sleep disorders and stimulants help people with attention-deficit hyperactivity disorder (ADHD) focus their attention. Most people who take prescription medications use them responsibly. But when abused—that is, taken by someone other than the patient for whom the medication was prescribed or taken in a manner or dosage other than what was prescribed—prescription medications can produce serious adverse health effects, including addiction. [Pg.233]

A9-Tetrahydrocannabinol (A9-THC) is considered to be the predominant compound in preparations of C. sativa (marijuana, hashish, bhang) that is responsible for the central nervous system effects in humans. The recognized central nervous system responses to these preparations include alterations in cognition and memory, euphoria, and sedation. Potential therapeutic applications of cannabis preparations that are of either historical or contemporary interest include analgesia, attenuation of the nausea and vomiting of cancer chemotherapy, appetite stimulation, decreased intestinal motility of diarrhea, decreased bronchial constriction of asthma, decreased intraocular pressure of glaucoma, antirheumatic and antipyretic actions, and treatment of convulsant disorders. These effects have been reviewed recently (Howlett, 1995). [Pg.226]

Dextroamphetamines are a part of the amphetamine class of drugs, central nervous system (CNS) stimulants that are used in the treatment of certain brain-based disorders. Because of their long-lasting and potent stimulant effects, they are also highly physically and psychologically addictive and have a high rate of abuse. [Pg.138]

List of Abbreviations Ach, acetylcholine AMPA, a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid CNS, central nervous system COMT, catechol-O-methyltransferase DA, dopamine DRP-2, dihy-dropyrimidinase-related protein 2 DSM, diagnostic and statistical manual of mental disorders GNAS1, guanine nucleotide-binding protein (G-protein) alpha stimulating activity polypeptide 1 5-HIAA, 5-hydroxyindole acetic acid 5-FIT, serotonin (5-hydroxytryptamine) MAO, monoamine oxidase MHPG, 3-methoxy-4-hydroxyphenylglycol NE, norepinephrine NMDA, N-methyl-D-aspartate PCP, phencyclidine SSRI, selective serotonin reuptake inhibitor SDS, schedule for the deficit syndrome... [Pg.508]


See other pages where Central nervous system stimulants disorder is mentioned: [Pg.5]    [Pg.147]    [Pg.178]    [Pg.188]    [Pg.15]    [Pg.399]    [Pg.1262]    [Pg.8]    [Pg.105]    [Pg.237]    [Pg.410]    [Pg.242]    [Pg.169]    [Pg.250]    [Pg.61]    [Pg.52]    [Pg.224]    [Pg.231]    [Pg.351]    [Pg.8]    [Pg.453]    [Pg.698]    [Pg.180]    [Pg.2307]    [Pg.259]    [Pg.1733]    [Pg.86]    [Pg.1421]   
See also in sourсe #XX -- [ Pg.409 ]




SEARCH



Central disorders

Central nervous system disorders

Central nervous system stimulating

Central stimulants

Disordered systems

Nervous disorders

© 2024 chempedia.info